Want a better way to submit grants electronically? Find out the pros and cons of the most widely-used programs.

A Web-based program, ranging from $495 for an individual yearly subscription up to $500,000 per institution, Cayuse allows users to work online without downloading or needing to integrate any additional programs. /2008/4/1/93/1/ Click to Submit no /2008/4/1/94/2/ ProposalCENTRAL no /2008/4/1/95/1/ Customizable Product Suites no

This Web-based program was developed in conjunction with 43 private granting foundations. The cost for these granting agencies to design an application through ProposalCENTRAL can range from about $15,000 to $150,000 per granting agency. It's free to users, however, who submitted 9,300 applications through ProposalCENTRAL in 2007. /2008/4/1/93/1/ Click to Submit no

Companies such as Click Commerce, InfoEd, and COEUS have developed customized systems for each institution that can include IRB approval applications for clinical trials and approval for testing and research with animals. /2008/4/1/93/1/ Click to Submit no /2008/4/1/94/1/ Cayuse no /2008/4/1/94/2/ ProposalCENTRAL no

At the end of last year, The Scientist editors spotted a linkurl:warning notice;http://www.quantabio.com/bio-rad.php on the Quanta Biosciences Web site that their supply relationship with Bio-Rad had been terminated. In particular, certain PCR reagents that Quanta had been manufacturing for Bio-Rad were no longer the same and Bio-Rad was now making its own formulations. The key question is: Are the reagents any different? If so, how? The answer, so far, has proved elusive. I heard from severa

The conversation is not over regarding two recent retractions of papers on enzyme engineering. Two letters linkurl:published;http://www.sciencemag.org/cgi/eletters/319/5863/569b this month in Science say that the explanation of retraction issued by linkurl:Homme Hellinga's;http://www.biochem.duke.edu/faculty/homme-hellinga group at Duke University does not account for many of the errors in the original publications. The linkurl:Grantsmanship blog;http://writedit.wordpress.com/2008/02/01/science

The New York Times linkurl:reported;http://www.nytimes.com/2008/03/26/health/research/26lung.html?pagewanted=1&_r=1&hp&adxnnlx=1206540626-U/Hi/ilxjsfY10QFkfyPCg today (March 26) that a major tobacco company -- the Liggett Group -- sponsored a controversial lung cancer study last year totaling about $3.6 million in grants. Interestingly enough, I got an Email a couple of weeks ago from linkurl:Stanton Glantz,;http://cancer.ucsf.edu/people/glantz_stanton.php University of California researcher and

At the National Institutes of Health linkurl:open meeting;http://www.the-scientist.com/blog/display/54421/ on the new public access mandate yesterday (March 20), publishers continued to criticize the plan and called for the agency to delay implementing it. As part of the Congressional linkurl:appropriations act;http://www.the-scientist.com/blog/display/54028/ for FY2008, all articles arising from research funded by NIH funds must be submitted to PubMed Central within 12 months of publication.

Researchers have identified a master protein that regulates some 1,000 genes controlling for tumor growth and metastasis in breast cancer, according to a linkurl:paper;http://www.nature.com/nature/journal/v452/n7184/abs/nature06781.html published today in Nature. The researchers, led by linkurl:Terumi Kohwi-Shigematsu;http://www.lbl.gov/lifesciences/labs/kohwi-shigematsu_lab.html at Lawrence Berkeley National Laboratory, stumbled upon SATB1's heightened expression while screening aggressive hum

The US Patent and Trademark Office has upheld the two remaining stem cell patents out of a contested trio held by the Wisconsin Alumni Research Foundation (WARF), according to the final ruling posted last week by the USPTO. The third patent was upheld in a ruling last month (read more linkurl:here);http://www.the-scientist.com/blog/display/54389/ and can still be challenged by appeal. Last week's rulings are final and cannot be appealed. "The patent office has conducted a thoughtful and thoro

The National Institutes of Health is seeking public comment on its new public access mandate, according to an linkurl:announcement;http://publicaccess.nih.gov/comments.htm the NIH posted Friday on their Web site. To submit your comment to the NIH click linkurl:here.;http://publicaccess.nih.gov/comments/comments.htm Some 50 commenters will be given five minutes each to present their comments at a meeting next Thursday (March 20) in Bethesda, Md. The NIH implemented a public access mandate in J

The National Institute of Child Health and Human Development (NICHD) will likely close 12 intramural labs, Science linkurl:reported;http://www.sciencemag.org/cgi/content/summary/319/5868/1324a last Friday. The NICHD may close the labs as part of $15 million in savings, according to Emails sent to Science and circulated to employees. Michael Gottesman, NIH deputy director of intramural research, said that this isn't the first time the intramural research program has been downsized, and that NIC